Blockbuster potential
Biotica selects projects of high commercial as well as clinical importance.
High unmet need
For each project, Biotica, together with its therapeutic advisors, analyses current treatment methods in the chosen therapeutic area to identify a target product profile (TPP) that satisfies genuine unmet need. Biotica reviews any existing products on the market or in the development pipeline to ensure a polyketide therapeutic meeting the TPP will be competitive, and analyses the patient potential to ensure the market size is sufficient for commercial success.
Attractive to partners
During the early stages of a polyketide therapeutic programme, Biotica solicits feedback from pharmaceutical companies to ensure that the project will be partnerable. This also helps to identify key studies that are required to demonstrate proof-of-concept for potential partners.
